US$ 26.44
glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Drug mechanism of action of analogues, DPP-IV inhibitors, DPP-4 Inhibitors: What Is Their
Description
doi: 10.2337/db13-0227

Also, high prices of GLP-1RAs due to their use in obesity management limit access to newer diabetes medicines in LMICs

Epub 2019 May 14

doi: 10.1210/jcem.81.1.8550773

[DOI] [PMC free article] [PubMed] [Google Scholar] 133.Heimbrger SM, et al
